About BCI Pharma
BCI Pharma is a company based in Grabels (France) founded in 2013 was acquired by Gedeon Richter in June 2024.. BCI Pharma has raised $4.7 million across 1 funding round from investors including Gedeon Richter and Wallonia. BCI Pharma offers products and services including Medicinal Chemistry Platform, Biology Platform, and Kinase Inhibitor Platform. BCI Pharma operates in a competitive market with competitors including Reaction Biology, ImmunoSCAPE, PhenoVista, Discovery Biomed and ICE Bioscience, among others.
- Headquarter Grabels, France
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$4.7 M (USD)
in 1 rounds
-
Latest Funding Round
$4.7 M (USD), Series A
Mar 12, 2018
-
Investors
Gedeon Richter
& 1 more
-
Employee Count
Employee Count
-
Acquired by
Gedeon Richter
(Jun 19, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of BCI Pharma
BCI Pharma offers a comprehensive portfolio of products and services, including Medicinal Chemistry Platform, Biology Platform, and Kinase Inhibitor Platform. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Platform for discovering novel kinase inhibitors.
Tools for biological testing in drug discovery processes.
Technology to develop potent inhibitors for medical applications.
Unlock access to complete
Unlock access to complete
Funding Insights of BCI Pharma
BCI Pharma has successfully raised a total of $4.7M through 1 strategic funding round. The most recent funding activity was a Series A round of $4.7 million completed in March 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series A — $4.7M
-
First Round
First Round
(12 Mar 2018)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2018 | Amount | Series A - BCI Pharma | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in BCI Pharma
BCI Pharma has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Gedeon Richter and Wallonia. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Access to government programs and development services is facilitated.
|
Founded Year | Domain | Location | |
|
Generic and biosimilar drugs are manufactured by Gedeon Richter.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by BCI Pharma
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - BCI Pharma
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Bci Pharma Comparisons
Competitors of BCI Pharma
BCI Pharma operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Reaction Biology, ImmunoSCAPE, PhenoVista, Discovery Biomed and ICE Bioscience, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
In vitro enzyme activity assays, secializing in kinase & epigenetic HTS and profiling
|
|
| domain | founded_year | HQ Location |
High-dimensional immune profiling services are delivered via proprietary platform.
|
|
| domain | founded_year | HQ Location |
A CRO that provides phenotypic assay development and screening services.
|
|
| domain | founded_year | HQ Location |
Custom human cell engineering and drug discovery services are provided.
|
|
| domain | founded_year | HQ Location |
Specialised CRO offering a range of screening platforms for cardiac safety testing, ion channel profiling and in vitro HTS screening
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Bci Pharma
Frequently Asked Questions about BCI Pharma
When was BCI Pharma founded?
BCI Pharma was founded in 2013 and raised its 1st funding round 5 years after it was founded.
Where is BCI Pharma located?
BCI Pharma is headquartered in Grabels, France. It is registered at Grabels, Herault, France.
Is BCI Pharma a funded company?
BCI Pharma is a funded company, having raised a total of $4.7M across 1 funding round to date. The company's 1st funding round was a Series A of $4.7M, raised on Mar 12, 2018.
What does BCI Pharma do?
BCI Pharma was founded in 2013 and is based in Grabels, France. Operations focus on the pharmaceutical sector as a contract research organization, with projects centered on cancer, neuropathic pain, inflammation, and neuroinflammation related to multiple sclerosis, Alzheimers, and ALS. Chemical libraries, including kinase and macrocyclic peptide types, are developed. Services encompass library synthesis, medicinal chemistry, and consultancy to support drug discovery processes.
Who are the top competitors of BCI Pharma?
BCI Pharma's top competitors include ImmunoSCAPE, Quantumcyte and Reaction Biology.
What products or services does BCI Pharma offer?
BCI Pharma offers Medicinal Chemistry Platform, Biology Platform, and Kinase Inhibitor Platform.
Who are BCI Pharma's investors?
BCI Pharma has 2 investors. Key investors include Gedeon Richter, and Wallonia.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.